EHDN & Enroll-HD 2024
The EHDN 2024 meeting in Strasbourg holds significant importance as it serves as one of the key global gatherings dedicated to Huntington’s Disease (HD). This event acts as a crucial platform for fostering international collaboration between scientists, clinicians, advocacy groups, and families affected by HD. By combining the EHDN Plenary Meeting with the Enroll-HD Congress, it becomes a focal point for sharing the latest advancements in HD research, from basic science to clinical applications.
This global meeting plays an essential role in uniting the HD community, offering opportunities for networking, discussing groundbreaking discoveries, and strategizing future efforts in the pursuit of effective treatments and care. The collaborative spirit of this event is key in driving progress and maintaining momentum in the global fight against Huntington’s Disease.
In addition to the discussions on research advancements, the Swiss Huntington team was present at the meeting, demonstrating their ongoing commitment to research and care for Huntington’s disease. During the event, the team actively participated in various sessions, sharing their findings and collaborating with international colleagues.
The interactions with other delegates facilitated a valuable exchange of ideas, enriching mutual understanding of the challenges and opportunities in HD research. It is expected that the synergies created at this meeting will significantly contribute to upcoming clinical studies and care initiatives in Switzerland, further strengthening teamwork in the fight against Huntington’s disease.
